JP2001520991A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001520991A5 JP2001520991A5 JP2000517704A JP2000517704A JP2001520991A5 JP 2001520991 A5 JP2001520991 A5 JP 2001520991A5 JP 2000517704 A JP2000517704 A JP 2000517704A JP 2000517704 A JP2000517704 A JP 2000517704A JP 2001520991 A5 JP2001520991 A5 JP 2001520991A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- spla
- dioxoethyl
- indol
- ylmethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6328097P | 1997-10-27 | 1997-10-27 | |
| US60/063,280 | 1997-10-27 | ||
| PCT/US1998/022690 WO1999021546A1 (en) | 1997-10-27 | 1998-10-26 | N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001520991A JP2001520991A (ja) | 2001-11-06 |
| JP2001520991A5 true JP2001520991A5 (https=) | 2006-01-05 |
Family
ID=22048164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000517704A Withdrawn JP2001520991A (ja) | 1997-10-27 | 1998-10-26 | インドールｓＰＬＡ２阻害剤のＮ，Ｎ−ジエチルグリコールアミドエステルプロドラッグ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6274616B1 (https=) |
| EP (1) | EP1030661A4 (https=) |
| JP (1) | JP2001520991A (https=) |
| AU (1) | AU1279899A (https=) |
| CA (1) | CA2309135A1 (https=) |
| WO (1) | WO1999021546A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9501404A (pt) * | 1994-04-01 | 1996-03-05 | Lilly Co Eli | 1H-indol-3 glioxilamida e formulação farmacèutica |
| JP2003505372A (ja) * | 1999-07-19 | 2003-02-12 | イーライ・リリー・アンド・カンパニー | ｓＰＬＡ２インヒビター |
| US6706752B1 (en) | 1999-07-19 | 2004-03-16 | Eli Lilly And Company | sPLA2 inhibitors |
| DE60032254D1 (de) * | 1999-09-20 | 2007-01-18 | Lilly Co Eli | Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren |
| US6831095B1 (en) | 1999-09-20 | 2004-12-14 | Eli Lilly And Company | Hydroxyfunctional amide 1h-indole derivatives active as sPLA2 inhibitors |
| DE19962300A1 (de) * | 1999-12-23 | 2001-06-28 | Asta Medica Ag | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
| EP1303262A2 (en) * | 2000-07-14 | 2003-04-23 | Eli Lilly And Company | Use of a spla2 inhibitor for the treatment of sepsis |
| NZ624963A (en) | 2009-04-29 | 2016-07-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9501404A (pt) * | 1994-04-01 | 1996-03-05 | Lilly Co Eli | 1H-indol-3 glioxilamida e formulação farmacèutica |
| US5641800A (en) * | 1994-07-21 | 1997-06-24 | Eli Lilly And Company | 1H-indole-1-functional sPLA2 inhibitors |
| US5972988A (en) * | 1997-03-26 | 1999-10-26 | Eli Lilly And Company | Method for treatment of chronic bronchitis using indole compounds |
| AU1200799A (en) * | 1997-10-27 | 1999-05-17 | Eli Lilly And Company | Isopropyl ester prodrugs of indole spla2 inhibitors |
-
1998
- 1998-10-26 CA CA002309135A patent/CA2309135A1/en not_active Abandoned
- 1998-10-26 WO PCT/US1998/022690 patent/WO1999021546A1/en not_active Ceased
- 1998-10-26 AU AU12798/99A patent/AU1279899A/en not_active Abandoned
- 1998-10-26 JP JP2000517704A patent/JP2001520991A/ja not_active Withdrawn
- 1998-10-26 EP EP98956223A patent/EP1030661A4/en not_active Withdrawn
-
2000
- 2000-03-29 US US09/509,754 patent/US6274616B1/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001520998A5 (https=) | ||
| JP2002518502A5 (https=) | ||
| AU3392900A (en) | Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds | |
| CA2301017A1 (en) | Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds | |
| CA2445145A1 (en) | Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes | |
| JP2004508410A5 (https=) | ||
| DE69924869D1 (de) | Medikament zur behandlung chronisch obstruktiver lungenerkrankung | |
| NO20071498L (no) | Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet | |
| AU2002346973A1 (en) | Oral Dosage Form for Propiverine or its Pharmaceutically Acceptable Salts with an Extended Release of the Active Ingredient | |
| WO1999047497A3 (en) | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment | |
| JP2003503449A5 (https=) | ||
| JP2002509153A5 (https=) | ||
| JP2002502836A5 (https=) | ||
| AU1200899A (en) | Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors | |
| JP2001520991A5 (https=) | ||
| JP2002520286A5 (https=) | ||
| JP2002513761A5 (https=) | ||
| JP2004532828A5 (https=) | ||
| PL351378A1 (en) | Process for the preparation of carboxylic acid salts from primary alcohols | |
| WO2001019819A3 (en) | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment | |
| JP2003522768A5 (https=) | ||
| JPH1036365A5 (https=) | ||
| AU2001242376A1 (en) | Process for the preparation of 2-hydroxy-4-methylthiobutyric acid esters | |
| JP2003509494A5 (https=) | ||
| ATE280155T1 (de) | Inhibitorische ester für spla 2 |